Published: 29-05-2017 14:11 | Updated: 18-02-2022 10:37

NEWS SFO StratRegen

The Nobel Symposium and the 2nd SFO StratRegen Conference is planned to place in October 2022.

The SFO for Stem Cells and Regenerative Medicine is proud to announce twelve awardees in the 2021 application round. All applications were reviewed by an international team of five prominent researchers within the field.

Nobel Symposium 2022

Welcome to the Nobel Symposium “From models towards regenerative therapies” at Nobel Forum, 12 October 2022. Read more about Nobel Symposium

SFO StratRegen Conference 2022

The 2nd StratRegen Conference:“Stem cells, regeneration biology and regenerative medicine”. The conference will take place at Yasuragi, Stockholm, 13-14 October 2022. Read more about the 2nd StratRegen Conference.

SFO grant awardees 2021

Senior grant awardees

1. Jonas Frisén - Building relay circuits from resident neural stem cells

2. Christian Göritz - Elucidating the regenerative potential of astrocyte-derived striatal neurogenesis

3. Maria Kasper - Decoding molecular and cellular mechanisms controlling self-renewal and regeneration of skin

4. Roman Zubarev - Development of ultra-pure progenitors using plurifaceted single-cell proteomics

Junior grant awardees

1. Yenan Bryceson - Deciphering the function of SAMD9 and SAMD9L tumor suppressors in stemcell disorders

2. Pauliina Damdimopoulou - Regenerating human ovaries in vitro

3. Qiaolin Deng - Revealing deleterious gene dosage effects on germline specification and testicular stem cell niche in Klinefelter syndrome by single-cell technology

4. Phillip Newton - How is human growth maintained throughout childhood?

5. Björn Reinius - Modes and mechanisms of dosage compensation upon chromosome copy number imbalance

6. Georgios Sotiriou - Bone tissue engineering by stem cells and calcium phosphate nanobiomaterials

Clinical grant awardees

1. Mikael Svensson - Clinical grade human neural stem/progenitor cell therapy for chronic spinalcord injury

2. Magnus Tobiasson - Prediction of relapse after allogeneic stem cell transplantation by identifying patient- specific mutations in the hematopoietic stem and progenitor cell compartment in patients with myelodysplastic syndrome

Read more about the research projects